Faron Pharmaceuticals Oy (LON:FARN – Get Free Report) shares passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 177.48 ($2.29) and traded as high as GBX 190 ($2.45). Faron Pharmaceuticals Oy shares last traded at GBX 185 ($2.39), with a volume of 9,756 shares trading hands.
Faron Pharmaceuticals Oy Trading Up 2.3 %
The company has a debt-to-equity ratio of 922.55, a quick ratio of 1.09 and a current ratio of 1.45. The company has a market cap of £260.99 million, a P/E ratio of -5.20 and a beta of 0.36. The stock has a 50-day moving average of GBX 177.37 and a two-hundred day moving average of GBX 185.89.
About Faron Pharmaceuticals Oy
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
Featured Articles
- Five stocks we like better than Faron Pharmaceuticals Oy
- 5 discounted opportunities for dividend growth investors
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- Should You Invest in Penny Stocks?
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
